Guardant Health Inc is a precision oncology company. It is focused on helping conquer cancer globally through the use of proprietary blood tests, vast data sets, and advanced analytics. The company only reportable segment: delivering precision oncology testing and development services. Geographically, the company generates a majority of its revenue from the United States. its solutions include treatment selection, recurrence, and early detection.